Barclays analyst Lauren Lieberman raised the firm’s price target on Clorox (CLX) to $140 from $130 and keeps an Underweight rating on the shares. The company’s enterprise resource planning implementation should drive margin growth, but sales growth “remains an open question and will be for some time,” the analyst tells investors in a research note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue